A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: A report from the Pediatric Brain Tumor Consortium
Ian F. Pollack(Children's Hospital of Pittsburgh), J. Russell Geyer(St. Jude Children's Research Hospital), Alberto Broniscer(St Nicholas Hospital), Clinton F. Stewart(St. Jude Children's Research Hospital), Anuradha Banerjee(University of California, San Francisco), L. Kun(Radiation Oncology Associates), James M. Boyett(University of Illinois Chicago), Tina Young Poussaint(Seattle Children's Hospital), James G. Douglas(University of Washington), Mehmet Koçak(St. Jude Children's Research Hospital)
Cited by 130
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
|Journal of Clinical Oncology|2010|657
Subgroup-Specific Prognostic Implications of <i>TP53</i> Mutation in Medulloblastoma
|Journal of Clinical Oncology|2013|488
Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group
|Journal of Clinical Oncology|2012|433